news
New drug for Huntington lowers levels of disease-causing protein
A new drug for Huntington disease is found to be safe and lowers levels of the abnormal protein that causes the debilitating disease in patients.
List view / Grid view
University College London
news
No association found between trazodone and reduced risk of dementia
The antidepressant drug, trazodone, taken for anxiety and depression, has been found not to be linked to a reduced risk of dementia...
news
Vaccine facility targets development and manufacturing to fight pandemics
The new hub is designed to speed the response to deadly pandemics by improving the development and manufacturing of vaccines – particularly in low- and middle-income countries...
news
Gene therapy receives Champalimaud Vision Award
The Champalimaud Vision Award has been awarded to research teams for the development of a gene therapy...
news
Researchers to investigate screening for prostate cancer using MRI
A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately...
news
Test for antibiotic associated kidney damage in children with CF identified
New research highlights effective methods for identifying a common side effect in children receiving drug treatments for Cystic fibrosis...
news
NPL launches Metrology for Medical Physics Centre, MEMPHYS
MEMPHYS will work closely with the NHS, academia and industry to enable the rapid and widespread implementation of a host of new diagnostic and therapeutic technologies.
news
Lansoprazole a gastric acid suppressant may target TB
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause TB...
news
PI3K inhibitors show hope for rare bone cancers
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...
news
National Physical Laboratory re-launched to improve access to health innovations
NPL's new approach informed by government priorities, consultancy with industry and the NHS, and a century of expertise, will see it focus on some of the world’s biggest health challenges, from supporting the diagnosis and treatment of cancer and dementia, to reducing attrition rates in drug development, to creating new…
news
New imaging technique may predict the spread of breast cancer
Researchers have developed a new imaging technique to detect myeloid-derived suppressor cells’ accumulating in the lung...
news
Low-cost drugs package saves lives of people starting HIV treatment late
Treating people who start HIV treatment late with a package of low-cost drugs to prevent serious infections saves three lives for ...
news
Study predicts 1.2 million people in UK will be living with dementia by 2040
By 2040, there will be over 1.2 million people living with dementia in England and Wales (an increase of 57% from 2016), due to increased life expectancy...
news
Amber warning for the UK’s access to new medicines post Brexit
Independent health economist lays out solution for how the UK could handle pharmaceutical regulation after Brexit.
news
UCL Technology Fund invests £1m in gene therapy company, Freeline
20 June 2016 | By Victoria White, Digital Content Producer
Freeline is developing and commercialising gene therapies for bleeding and other life threatening or debilitating disorders...
